| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |